Study on the Effect of 40 Hz Non-Invasive Light Therapy System
NCT: NCT05260177 · RECRUITING
Brief Summary
The ALZLIGHT STAGE III Study is a continuation of the ALZLIGHT Pilot - Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System. As with the first two stages, this study will examine whether entrainment of 40 Hz neural oscillation by novel 40 Hz Invisible Spectral Flicker is a potential therapy for Alzheimer's Disease. In order to examine this, 62 patients with mild to moderate Alzheimer's Disease will be recruited. The patients will be exposed to the Non-Invasive Light Therapy System for 1 hour a day for 6 months. The effect will be measured by a combination of electroencephalography, cognitive testing, functional magnetic resonance imaging, magnetic resonance spectroscopy and actigraphy.
Frequently Asked Questions
What is Study on the Effect of 40 Hz Non-Invasive Light Therapy System?
Study on the Effect of 40 Hz Non-Invasive Light Therapy System is a clinical trial registered under NCT05260177. Current status: RECRUITING.
What is the status of NCT05260177?
The current status of NCT05260177 (Study on the Effect of 40 Hz Non-Invasive Light Therapy System) is: RECRUITING.
When did Study on the Effect of 40 Hz Non-Invasive Light Therapy System start?
Study on the Effect of 40 Hz Non-Invasive Light Therapy System started on 2022-09-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.